Type:Notice
Citation:90 FR 8719
Reading Time:about a minute or two
Catalent Greenville, Inc. has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. The company plans to use these substances for developing bulk dosage formulations for research and clinical trials. People or organizations that have an interest in this matter can submit comments or request a hearing by March 3, 2025. Submissions can be made through the Federal eRulemaking Portal, and hearings request should be sent to the DEA at specified addresses.
Simple Explanation
Catalent Greenville, Inc. wants to bring special medicine parts from other countries for science projects, and people who care about this can say what they think before early March 2025.